VHS Childrens Hospital of Michigan INC

VHS Childrens Hospital of Michigan INC was paid $180.24M by Medicaid between Jan 2018 and Dec 2024, across 612 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.

33Billing provider infoVHS CHILDRENS HOSPITAL OF MICHIGAN INC
DETROIT, MI 48201

33aNPI1538471800assigned 07/02/2010

33bProvider typeAmbulatory Surgical Clinic/Center

28Total paid$180.24M

24GClaims3,915,408

24DCodes billed612

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Ambulatory Surgical Clinic/Center providers in Michigan

Rank by total paid#1 of 48

Median peer was paid$97K

This provider vs. median1,863×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	556,405	$26.09M
2019	611,199	$24.98M
2020	452,243	$17.69M
2021	566,572	$25.65M
2022	610,919	$28.26M
2023	603,032	$29.09M
2024incomplete	515,038	$28.48M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	15%	219,205	210,319	$27.81M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	14%	456,204	408,601	$25.84M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	9.4%	39,805	38,508	$16.99M
42820	Tonsillectomy and adenoidectomy; younger than age 12	6.4%	4,376	4,354	$11.61M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	6.4%	52,315	51,143	$11.51M
G0378	Hospital observation service, per hour	5.6%	20,848	20,269	$10.12M
41899	Unlisted procedure, dentoalveolar structures	2.2%	3,666	3,649	$4.05M
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	1.6%	2,571	2,443	$2.83M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.5%	10,570	10,279	$2.76M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	1.2%	8,581	8,306	$2.15M
97530	Therapeutic activities, direct patient contact, each 15 minutes	1.1%	43,105	11,697	$1.92M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.1%	22,054	21,847	$1.90M

600 more codes

99281	Emergency department visit for the evaluation and management, self-limited or minor	1.0%	31,815	$1.83M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	3,723	$1.73M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	3,415	$1.73M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	4,293	$1.69M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	39,810	$1.61M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	4,035	$1.56M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	25,367	$1.55M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	24,189	$1.49M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	22,201	$1.37M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	7,822	$1.29M
42830		<1%	877	$1.24M
92587		<1%	8,546	$1.21M
54161		<1%	1,742	$1.15M
95782		<1%	2,293	$1.13M
P9016	Red blood cells, leukocytes reduced, each unit	<1%	6,824	$1.11M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	1,282	$1.11M
G0379	Direct admission of patient for hospital observation care	<1%	1,890	$1.11M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	14,564	$914K
76770		<1%	11,688	$912K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	28,204	$911K
36455		<1%	4,449	$908K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	9,355	$901K
71046	Radiologic examination, chest; 2 views	<1%	28,464	$878K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	5,172	$851K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	13,287	$801K
36430		<1%	3,882	$796K
67311		<1%	701	$765K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	17,525	$738K
95716		<1%	1,253	$675K
70543		<1%	623	$669K
95951		<1%	1,539	$667K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	552	$637K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	12,065	$633K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	7,512	$601K
90472	Immunization administration, each additional vaccine (list separately)	<1%	34,114	$565K
96361	Intravenous infusion, hydration; each additional hour	<1%	14,668	$519K
J7050	Infusion, normal saline solution, 250 cc	<1%	11,846	$518K
95816		<1%	3,982	$509K
54640		<1%	327	$498K
92523		<1%	4,419	$490K
95715		<1%	1,654	$462K
76825		<1%	1,579	$456K
93975		<1%	4,688	$437K
64642		<1%	871	$418K
95700		<1%	3,635	$418K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	41,283	$413K
36591		<1%	2,188	$411K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,607	$409K
92526		<1%	8,736	$396K
96409		<1%	3,297	$392K
67312		<1%	212	$380K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	6,471	$354K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	404	$350K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	703	$337K
31575		<1%	2,462	$316K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	15,615	$314K
29075		<1%	1,753	$313K
72197		<1%	372	$312K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	4,328	$281K
70450	Computed tomography, head or brain; without contrast material	<1%	5,177	$269K
99381		<1%	4,007	$255K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	6,742	$254K
97116		<1%	9,105	$251K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	9,845	$239K
16020		<1%	4,113	$229K
44970		<1%	84	$228K
97760		<1%	4,692	$219K
90670		<1%	16,095	$214K
96375	Therapeutic injection; each additional sequential IV push	<1%	10,488	$210K
78815	Positron emission tomography (PET) for limited area imaging	<1%	315	$209K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	324	$201K
99218		<1%	393	$198K
54150		<1%	175	$193K
29065		<1%	1,046	$192K
72141		<1%	542	$189K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	114,950	$187K
54360		<1%	111	$186K
49500		<1%	105	$184K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	20,378	$180K
V5264	Ear mold/insert, not disposable, any type	<1%	4,301	$171K
97163		<1%	3,320	$168K
42821		<1%	104	$162K
71045	Radiologic examination, chest; single view	<1%	5,756	$161K
72156		<1%	81	$157K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	86	$148K
54163		<1%	145	$144K
70486		<1%	1,720	$139K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	4,035	$139K
96415		<1%	3,622	$137K
92551		<1%	19,156	$130K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	3,141	$128K
82728		<1%	25,695	$117K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	24,871	$107K
97167		<1%	2,057	$106K
29515		<1%	1,438	$92K
92588		<1%	882	$92K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	9,822	$91K
74183		<1%	559	$90K
90378		<1%	68	$89K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	6,500	$86K
90651		<1%	3,425	$85K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	642	$84K
80053	Comprehensive metabolic panel	<1%	34,810	$84K
86902		<1%	4,294	$84K
83655		<1%	13,640	$83K
80048	Basic metabolic panel (calcium, ionized)	<1%	34,964	$79K
36416		<1%	15,578	$77K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	9,798	$76K
87631		<1%	17,917	$76K
84443	Thyroid stimulating hormone (TSH)	<1%	18,082	$76K
94010		<1%	9,993	$75K
20680		<1%	52	$72K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	3,220	$71K
76536		<1%	3,070	$71K
69210		<1%	2,782	$70K
96450		<1%	501	$70K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,314	$68K
17110		<1%	74	$67K
P9011	Blood, split unit	<1%	948	$67K
95117		<1%	3,219	$66K
29105		<1%	1,008	$64K
25605		<1%	71	$64K
J1756	Injection, iron sucrose, 1 mg	<1%	777	$63K
83735		<1%	28,615	$61K
88184		<1%	708	$61K
51784		<1%	881	$60K
90474		<1%	10,396	$59K
92585		<1%	671	$59K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	33,005	$58K
92579		<1%	8,943	$58K
86900		<1%	15,670	$58K
80061	Lipid panel	<1%	6,023	$55K
74455		<1%	467	$54K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	2,445	$52K
85046		<1%	41,717	$52K
81003		<1%	32,746	$52K
G0008	Administration of influenza virus vaccine	<1%	6,292	$50K
92626		<1%	1,737	$50K
83036	Hemoglobin; glycosylated (A1C)	<1%	13,520	$50K
92557		<1%	5,187	$49K
81025		<1%	23,720	$48K
84460		<1%	38,216	$47K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	29,064	$47K
84450		<1%	38,181	$46K
90620		<1%	1,960	$44K
74018		<1%	12,042	$43K
10060		<1%	513	$41K
84439		<1%	16,900	$41K
92552		<1%	7,882	$39K
97162		<1%	807	$39K
51600		<1%	422	$38K
93886		<1%	305	$38K
92586		<1%	547	$38K
82947		<1%	4,507	$37K
77072		<1%	2,270	$37K
90686		<1%	15,247	$37K
97161		<1%	910	$36K
82784		<1%	17,472	$36K
72082		<1%	5,427	$36K
96367		<1%	1,123	$35K
29405		<1%	171	$35K
86832		<1%	723	$34K
82465		<1%	7,140	$34K
86833		<1%	721	$34K
36415	Collection of venous blood by venipuncture	<1%	64,696	$34K
86140		<1%	29,111	$34K
92018		<1%	36	$33K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	5,023	$33K
A9270	Non-covered item or service	<1%	181,407	$33K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	733	$33K
12011		<1%	2,735	$32K
87799		<1%	3,569	$32K
Q3014	Telehealth originating site facility fee	<1%	2,338	$32K
76506		<1%	992	$32K
G0009	Administration of pneumococcal vaccine	<1%	4,193	$32K
92595		<1%	1,069	$31K
86780		<1%	4,258	$31K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	37,752	$31K
83970		<1%	3,118	$30K
97166		<1%	593	$30K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	10,842	$29K
83718		<1%	6,496	$28K
90716		<1%	4,172	$28K
96411		<1%	774	$27K
80051		<1%	24,667	$27K
51741		<1%	506	$27K
51798		<1%	4,634	$27K
69200		<1%	841	$27K
43762		<1%	220	$25K
82565		<1%	23,266	$25K
83550		<1%	11,163	$25K
92567		<1%	31,499	$24K
67808		<1%	24	$24K
86850		<1%	15,296	$24K
J0475	Injection, baclofen, 10 mg	<1%	49	$23K
82805		<1%	14,677	$23K
83021		<1%	6,081	$23K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,748	$22K
82248		<1%	21,455	$22K
82247		<1%	20,471	$22K
83615		<1%	19,389	$22K
90734		<1%	4,042	$22K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	37	$22K
73560		<1%	2,570	$21K
84520		<1%	23,014	$20K
92582		<1%	2,863	$20K
J0690	Injection, cefazolin sodium, 500 mg	<1%	7,289	$20K
83540		<1%	11,786	$20K
70260		<1%	2,873	$19K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	284	$19K
87496		<1%	2,445	$19K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	20,594	$19K
84100		<1%	26,363	$19K
76882		<1%	1,454	$19K
92524		<1%	384	$19K
73521		<1%	2,816	$18K
82570		<1%	15,332	$18K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	957	$18K
85027		<1%	6,302	$18K
84075		<1%	17,847	$18K
92652		<1%	191	$17K
86923		<1%	3,773	$17K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	5,103	$17K
94060		<1%	138	$16K
83516		<1%	6,987	$16K
86880		<1%	11,952	$16K
74021		<1%	6,821	$15K
87086	Culture, bacterial; quantitative colony count, urine	<1%	21,742	$15K
24640		<1%	167	$15K
87536		<1%	353	$15K
92610		<1%	331	$15K
80069		<1%	2,629	$14K
85652		<1%	15,767	$14K
73130		<1%	5,083	$14K
86360		<1%	1,249	$14K
92019		<1%	15	$14K
86803		<1%	2,352	$14K
73630		<1%	6,630	$14K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	324	$13K
73610		<1%	6,516	$13K
12001		<1%	1,922	$13K
76870		<1%	2,004	$13K
81001		<1%	31,721	$13K
95713		<1%	44	$12K
62369		<1%	50	$12K
93226		<1%	417	$12K
76857		<1%	2,476	$12K
86359		<1%	1,285	$12K
84550		<1%	12,661	$12K
92591		<1%	222	$11K
73110		<1%	6,145	$11K
83690		<1%	9,747	$11K
83001		<1%	2,268	$11K
83002		<1%	2,278	$11K
74240		<1%	124	$11K
90656		<1%	143	$11K
S0077	Injection, clindamycin phosphate, 300 mg	<1%	1,876	$10K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	4,495	$10K
74241		<1%	107	$10K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	3,245	$10K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	862	$10K
80074		<1%	1,994	$10K
93017		<1%	308	$10K
84156		<1%	12,341	$10K
73564		<1%	3,260	$10K
87040		<1%	7,599	$10K
82977		<1%	5,985	$10K
80076		<1%	4,644	$9K
80197		<1%	3,270	$9K
72170		<1%	3,210	$9K
73590		<1%	5,194	$9K
85244		<1%	1,966	$9K
85240		<1%	2,029	$9K
J7070	Infusion, d5w, 1000 cc	<1%	3,598	$9K
73090		<1%	7,283	$9K
J7030	Infusion, normal saline solution , 1000 cc	<1%	17,209	$9K
82962		<1%	13,052	$9K
86870		<1%	101	$9K
86357		<1%	1,055	$9K
82043		<1%	6,462	$9K
86355		<1%	1,056	$9K
85576		<1%	1,089	$9K
82040		<1%	12,864	$9K
64643		<1%	726	$8K
86235		<1%	1,863	$8K
83605		<1%	15,084	$8K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	5,818	$8K
86038		<1%	2,954	$8K
84703		<1%	6,613	$8K
70360		<1%	1,994	$8K
29345		<1%	55	$8K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	787	$8K
31622		<1%	101	$8K
85245		<1%	1,373	$8K
82670		<1%	1,109	$8K
86901		<1%	15,659	$8K
93271		<1%	129	$8K
86922		<1%	2,862	$8K
93325		<1%	8,639	$7K
73080		<1%	6,133	$7K
70250		<1%	1,550	$7K
82550		<1%	3,995	$7K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	19,613	$7K
82330		<1%	15,346	$7K
84403		<1%	1,158	$7K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	5,826	$7K
86665		<1%	3,140	$7K
85610		<1%	8,882	$7K
86706		<1%	2,555	$7K
86376		<1%	2,169	$7K
85730		<1%	8,418	$7K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	15,509	$7K
86480		<1%	450	$7K
87077		<1%	5,711	$6K
82533		<1%	1,473	$6K
87081		<1%	5,182	$6K
86341		<1%	1,120	$6K
77073		<1%	1,998	$6K
73140		<1%	3,957	$6K
95714		<1%	162	$6K
72146		<1%	210	$6K
82310		<1%	6,399	$6K
76885		<1%	137	$6K
73552		<1%	2,676	$6K
83880		<1%	1,028	$5K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	10,130	$5K
72040		<1%	2,428	$5K
76827		<1%	1,519	$5K
82627		<1%	902	$5K
74019		<1%	1,186	$5K
86225		<1%	1,893	$5K
86003		<1%	3,194	$5K
83013		<1%	251	$5K
82607		<1%	1,324	$5K
72100		<1%	1,031	$5K
82131		<1%	1,040	$5K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	30,129	$5K
49452		<1%	16	$5K
93320		<1%	8,407	$5K
83020		<1%	1,943	$5K
82785		<1%	1,443	$5K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	72	$5K
86800		<1%	1,593	$5K
82150		<1%	4,160	$5K
73030		<1%	1,890	$5K
99383		<1%	67	$5K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	39	$5K
85384		<1%	1,997	$5K
83993		<1%	615	$5K
86364		<1%	1,582	$5K
29705		<1%	44	$4K
86769		<1%	259	$4K
72158		<1%	78	$4K
72125	Computed tomography, cervical spine; without contrast material	<1%	190	$4K
J2704	Injection, propofol, 10 mg	<1%	32,012	$4K
84145		<1%	709	$4K
94664		<1%	1,987	$4K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	558	$4K
29505		<1%	53	$4K
84305		<1%	1,943	$4K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	371	$4K
92522		<1%	78	$4K
95712		<1%	24	$4K
92556		<1%	8,622	$4K
86664		<1%	1,727	$4K
86905		<1%	199	$3K
84402		<1%	439	$3K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	5,802	$3K
86663		<1%	1,729	$3K
73060		<1%	1,604	$3K
73000		<1%	1,147	$3K
86039		<1%	1,053	$3K
87070		<1%	3,107	$3K
83520		<1%	1,643	$3K
S0080	Injection, pentamidine isethionate, 300 mg	<1%	834	$3K
92555		<1%	8,748	$3K
88342		<1%	1,052	$3K
73562		<1%	1,157	$3K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	15	$3K
12002		<1%	366	$2K
72157		<1%	40	$2K
73120		<1%	794	$2K
84478		<1%	767	$2K
84484		<1%	2,281	$2K
86147		<1%	522	$2K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	46	$2K
29125		<1%	2,200	$2K
30901		<1%	14	$2K
92594		<1%	150	$2K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	136	$2K
82340		<1%	1,805	$2K
83037		<1%	1,146	$2K
82274		<1%	500	$2K
72070		<1%	220	$2K
C1769	Guide wire	<1%	1,530	$2K
94375		<1%	27	$2K
88300		<1%	3,876	$2K
85732		<1%	1,145	$2K
95813		<1%	13	$2K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	6,962	$2K
94660		<1%	321	$2K
86431		<1%	1,119	$2K
83525		<1%	619	$2K
87467		<1%	407	$2K
77076		<1%	407	$2K
84155		<1%	1,883	$2K
87340		<1%	724	$2K
84134		<1%	897	$2K
J1644	Injection, heparin sodium, per 1000 units	<1%	3,128	$2K
95822		<1%	12	$2K
82652		<1%	358	$1K
87807		<1%	3,123	$1K
83930		<1%	919	$1K
88185		<1%	348	$1K
83498		<1%	421	$1K
84146		<1%	236	$1K
83921		<1%	364	$1K
85250		<1%	227	$1K
97165		<1%	29	$1K
86337		<1%	194	$1K
82803		<1%	789	$1K
86317		<1%	336	$1K
11900		<1%	13	$1K
73620		<1%	678	$1K
87046		<1%	907	$999.12
72081		<1%	806	$983.73
82746		<1%	246	$949.17
87045		<1%	887	$946.63
87205		<1%	2,233	$898.02
85379		<1%	780	$897.74
30300		<1%	55	$872.00
80230		<1%	91	$845.22
70480		<1%	12	$822.02
84702		<1%	318	$798.35
88312		<1%	437	$787.59
92650		<1%	485	$786.60
86255		<1%	282	$764.25
76642		<1%	40	$756.82
82105		<1%	162	$748.38
73100		<1%	580	$738.60
99152		<1%	322	$714.04
J0290	Injection, ampicillin sodium, 500 mg	<1%	798	$640.36
86709		<1%	213	$619.53
J2997	Injection, alteplase recombinant, 1 mg	<1%	13	$586.41
J1953	Injection, levetiracetam, 10 mg	<1%	276	$570.47
82010		<1%	818	$569.61
99156		<1%	243	$562.93
88304		<1%	1,979	$559.91
93243		<1%	39	$553.28
0001A		<1%	25	$542.56
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	17,565	$537.77
90473		<1%	144	$529.11
85247		<1%	78	$528.60
83090		<1%	125	$527.25
73070		<1%	496	$524.06
82024		<1%	256	$514.04
62322		<1%	242	$498.79
80164		<1%	98	$496.87
96376		<1%	2,269	$488.00
84466		<1%	100	$486.68
82747		<1%	122	$480.40
82379		<1%	147	$471.33
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	12	$459.17
84481		<1%	155	$438.35
80165		<1%	25	$435.42
89230		<1%	25	$412.85
82542		<1%	1,616	$412.50
93225		<1%	51	$402.27
80195		<1%	81	$401.79
90732		<1%	13	$400.41
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	543	$377.56
82139		<1%	68	$350.85
90680		<1%	10,321	$348.78
82985		<1%	211	$343.51
89050		<1%	601	$338.57
80177		<1%	117	$320.58
99155		<1%	133	$306.58
S5010	5% dextrose and 0.45% normal saline, 1000 ml	<1%	1,568	$305.36
87480		<1%	65	$288.69
87510		<1%	65	$288.69
86308		<1%	826	$288.61
86704		<1%	86	$287.36
84202		<1%	70	$285.12
99151		<1%	123	$275.12
82610		<1%	1,513	$270.00
84480		<1%	98	$261.84
82017		<1%	112	$255.22
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,101	$252.07
J9370	Vincristine sulfate, 1 mg	<1%	2,043	$247.82
87493		<1%	56	$245.22
V5011	Fitting/orientation/checking of hearing aid	<1%	902	$222.22
73600		<1%	42	$222.09
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	3,955	$219.31
90744		<1%	56	$216.42
87209		<1%	134	$208.57
85014		<1%	684	$199.03
86787		<1%	54	$189.49
84132		<1%	687	$180.45
84295		<1%	650	$170.22
87660		<1%	37	$164.77
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	428	$160.69
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	1,411	$146.85
82140		<1%	93	$132.66
88341		<1%	69	$129.46
S0028	Injection, famotidine, 20 mg	<1%	1,597	$128.49
86644		<1%	120	$123.40
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,602	$122.75
84681		<1%	147	$120.90
94680		<1%	135	$119.32
87338		<1%	16	$111.15
86200		<1%	68	$104.57
90633		<1%	8,265	$104.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	427	$103.88
87177		<1%	134	$103.27
86146		<1%	25	$102.81
86701		<1%	196	$101.70
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	134	$92.88
A9585	Injection, gadobutrol, 0.1 ml	<1%	1,128	$90.12
90647		<1%	10,611	$89.82
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,176	$89.79
84436		<1%	149	$87.62
73502		<1%	39	$86.98
90715		<1%	2,476	$85.97
P9041	Infusion, albumin (human), 5%, 50 ml	<1%	12	$75.39
85520		<1%	15	$71.78
88262		<1%	12	$70.91
94200		<1%	91	$69.66
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,860	$65.83
90723		<1%	10,688	$64.51
87529		<1%	99	$60.03
82157		<1%	27	$56.16
99157		<1%	28	$55.49
88275		<1%	12	$52.43
86765		<1%	42	$50.88
82438		<1%	38	$49.92
88271		<1%	12	$48.75
92558		<1%	266	$48.24
77075		<1%	12	$47.04
86645		<1%	82	$46.19
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	97	$44.78
90700		<1%	3,857	$44.52
83010		<1%	32	$40.88
73660		<1%	42	$40.35
90707		<1%	4,000	$38.85
J0736	Injection, clindamycin phosphate, 300 mg	<1%	80	$38.20
82180		<1%	14	$37.67
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	24,118	$35.79
Q9968	Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg	<1%	85	$33.21
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	24	$31.86
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	3,305	$28.72
J2060	Injection, lorazepam, 2 mg	<1%	384	$28.59
99213	Doctor's office visit, returning patient (routine)	<1%	18	$24.60
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	4,946	$24.22
84244		<1%	12	$22.93
84157		<1%	28	$19.26
76376		<1%	346	$18.65
88280		<1%	12	$17.14
90696		<1%	3,258	$15.05
82390		<1%	12	$14.24
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	8,928	$13.29
99214	Doctor's office visit, returning patient (more involved)	<1%	15	$10.80
82945		<1%	28	$8.92
82085		<1%	25	$4.00
J9260	Injection, methotrexate sodium, 50 mg	<1%	738	$1.88
85018		<1%	14	$1.31
S0030	Injection, metronidazole, 500 mg	<1%	14	$1.27
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	13	$0.72
85396		0%	227	$0.00
90710		0%	76	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	323	$0.00
A9576	Injection, gadoteridol, (prohance multipack), per ml	0%	3,511	$0.00
82272		0%	12	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	150	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	30	$0.00
94799		0%	52	$0.00
J1240	Injection, dimenhydrinate, up to 50 mg	0%	141	$0.00
51701		0%	58	$0.00
90713		0%	95	$0.00
A9575	Injection, gadoterate meglumine, 0.1 ml	0%	1,047	$0.00
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	0%	22	$0.00
82397		0%	19	$0.00
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	0%	58	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	75	$0.00
88313		0%	30	$0.00
A4565	Slings	0%	14	$0.00
76377		0%	146	$0.00
C1766	Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away	0%	689	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	207	$0.00
94760		0%	308	$0.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	77	$0.00
87181		0%	38	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	14	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	448	$0.00
86258		0%	20	$0.00
86353		0%	12	$0.00
88307		0%	28	$0.00
87425		0%	21	$0.00
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	0%	49	$0.00
29130		0%	13	$0.00
J1170	Injection, hydromorphone, up to 4 mg	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOYLE, SHERRI (CFO)